Sign In
2 Jan 2014 07:05
For immediate release
2 January 2014
MedicX Fund Limited
("MedicX Fund", the "Fund" or the "Company")
Total voting rights
In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares of the Company in issue as at 31 December 2013 was 340,763,155 (excluding treasury shares) with each share holding one voting right.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.
The Company also holds 20,682,625 ordinary shares in treasury.
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
MedicX Group +44 (0) 1483 869 500
Keith Maddin, Chairman
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer
Canaccord Genuity Limited +44 (0) 20 7523 8000
Andrew Zychowski /Lucy Lewis
Buchanan +44 (0) 20 7466 5000
Charles Ryland /Sophie McNulty
Information on MedicX Fund Limited
MedicX Fund Limited is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 123 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 31 people operating across the UK.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.
Follow the stocks
